tiprankstipranks
Wuxi Biologics (Cayman) Inc. (HK:2269)
:2269
Hong Kong Market
2269
Wuxi Biologics (Cayman)
RESEARCH TOOLSreports

Wuxi Biologics (Cayman) (2269) Stock Forecast & Price Target

55 Followers
See the Price Targets and Ratings of:

2269 Analyst Ratings

Strong Buy
10Ratings
Strong Buy
9 Buy
1 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Wuxi
Biologics (Cayman)
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

2269 Stock 12 Month Forecast

Average Price Target

HK$45.14
▲(29.04% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Wuxi Biologics (Cayman) in the last 3 months. The average price target is HK$45.14 with a high forecast of HK$54.22 and a low forecast of HK$36.99. The average price target represents a 29.04% change from the last price of HK$34.98.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"HK$14","55":"HK$55","24.25":"HK$24.3","34.5":"HK$34.5","44.75":"HK$44.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":54.22150053950999,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">HK$54.22</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45.1382358528,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">HK$45.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":36.99420099505568,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">HK$36.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,24.25,34.5,44.75,55],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.74,39.93088465688538,41.12176931377077,42.31265397065615,43.50353862754154,44.69442328442692,45.885307941312306,47.076192598197686,48.26707725508307,49.457961911968454,50.64884656885384,51.83973122573922,53.0306158826246,{"y":54.22150053950999,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.74,39.232171988676924,39.72434397735385,40.21651596603077,40.70868795470769,41.200859943384614,41.693031932061544,42.185203920738466,42.67737590941539,43.16954789809231,43.661719886769234,44.153891875446156,44.64606386412308,{"y":45.1382358528,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,38.74,38.605707768850436,38.47141553770088,38.33712330655131,38.20283107540175,38.06853884425219,37.93424661310262,37.79995438195306,37.66566215080349,37.53136991965393,37.39707768850437,37.2627854573548,37.128493226205244,{"y":36.99420099505568,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":15.5,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.56,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.42,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.45,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.8,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":25.65,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.35,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":40.98,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":36.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":31.44,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 41, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":35.86,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 52, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":38.74,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 43, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetHK$54.22Average Price TargetHK$45.14Lowest Price TargetHK$36.99
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CMB International Securities Analyst forecast on HK:2269
Jill Wu
CMB International Securities
CMB International Securities
HK$39
Buy
11.49%
Upside
Reiterated
03/26/26
WuXi Biologics: Robust Backlog, High-Margin Growth Drivers, and Capacity Expansion Underpin Buy Rating
Daiwa Analyst forecast on HK:2269
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$42
Buy
20.07%
Upside
Reiterated
03/26/26
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
CLSA Analyst forecast on HK:2269
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$47.3
Buy
35.22%
Upside
Reiterated
03/26/26
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of China Analyst forecast on HK:2269
Unknown Analyst
Bank of China
Not Ranked
Bank of China
HK$37
Buy
5.77%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Bank of China
CICC Analyst forecast on HK:2269
Unknown Analyst
CICC
Not Ranked
CICC
HK$45→HK$48
Buy
37.22%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from CICC
UOB Kay Hian Analyst forecast on HK:2269
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$45
Buy
28.64%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
Bank of America Securities Analyst forecast on HK:2269
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$39.5
Hold
12.92%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities
UBS Analyst forecast on HK:2269
Unknown Analyst
UBS
Not Ranked
UBS
HK$49.3
Buy
40.94%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UBS
Zhongtai Securities Analyst forecast on HK:2269
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
HK$50.1
Buy
43.22%
Upside
Reiterated
02/13/26
Zhongtai Securities Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
China Renaissance Analyst forecast on HK:2269
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$54.23
Buy
55.03%
Upside
Reiterated
02/10/26
China Renaissance Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Nomura Analyst forecast on HK:2269
Jialin Zhang
Nomura
Nomura
HK$37.36
Buy
6.80%
Upside
Reiterated
11/28/25
Morgan Stanley Analyst forecast on HK:2269
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$35→HK$45
Buy
28.64%
Upside
Reiterated
11/20/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on HK:2269
Ziyi Chen
Goldman Sachs
Goldman Sachs
HK$29.3→HK$33.5
Hold
-4.23%
Downside
Reiterated
10/17/25
Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Jefferies Analyst forecast on HK:2269
Unknown Analyst
Jefferies
Not Ranked
Jefferies
HK$50
Buy
42.94%
Upside
Reiterated
10/08/25
HSBC Analyst forecast on HK:2269
Linda Shu
HSBC
HSBC
HK$37.5→HK$45
Buy
28.64%
Upside
Reiterated
09/26/25
HSBC Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
CMB International Securities Analyst forecast on HK:2269
Jill Wu
CMB International Securities
CMB International Securities
HK$39
Buy
11.49%
Upside
Reiterated
03/26/26
WuXi Biologics: Robust Backlog, High-Margin Growth Drivers, and Capacity Expansion Underpin Buy Rating
Daiwa Analyst forecast on HK:2269
Unknown Analyst
Daiwa
Not Ranked
Daiwa
HK$42
Buy
20.07%
Upside
Reiterated
03/26/26
Daiwa Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
CLSA Analyst forecast on HK:2269
Unknown Analyst
CLSA
Not Ranked
CLSA
HK$47.3
Buy
35.22%
Upside
Reiterated
03/26/26
CLSA Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Bank of China Analyst forecast on HK:2269
Unknown Analyst
Bank of China
Not Ranked
Bank of China
HK$37
Buy
5.77%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from Bank of China
CICC Analyst forecast on HK:2269
Unknown Analyst
CICC
Not Ranked
CICC
HK$45→HK$48
Buy
37.22%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Buy from CICC
UOB Kay Hian Analyst forecast on HK:2269
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
HK$45
Buy
28.64%
Upside
Reiterated
03/26/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UOB Kay Hian
Bank of America Securities Analyst forecast on HK:2269
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
HK$39.5
Hold
12.92%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Receives a Hold from Bank of America Securities
UBS Analyst forecast on HK:2269
Unknown Analyst
UBS
Not Ranked
UBS
HK$49.3
Buy
40.94%
Upside
Reiterated
03/25/26
Wuxi Biologics (Cayman) (WXIBF) Gets a Buy from UBS
Zhongtai Securities Analyst forecast on HK:2269
Unknown Analyst
Zhongtai Securities
Not Ranked
Zhongtai Securities
HK$50.1
Buy
43.22%
Upside
Reiterated
02/13/26
Zhongtai Securities Reaffirms Their Buy Rating on Wuxi Biologics (Cayman) (WXIBF)
China Renaissance Analyst forecast on HK:2269
Unknown Analyst
China Renaissance
Not Ranked
China Renaissance
HK$54.23
Buy
55.03%
Upside
Reiterated
02/10/26
China Renaissance Remains a Buy on Wuxi Biologics (Cayman) (WXIBF)
Nomura Analyst forecast on HK:2269
Jialin Zhang
Nomura
Nomura
HK$37.36
Buy
6.80%
Upside
Reiterated
11/28/25
Morgan Stanley Analyst forecast on HK:2269
Laurence Tam
Morgan Stanley
Morgan Stanley
HK$35→HK$45
Buy
28.64%
Upside
Reiterated
11/20/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on HK:2269
Ziyi Chen
Goldman Sachs
Goldman Sachs
HK$29.3→HK$33.5
Hold
-4.23%
Downside
Reiterated
10/17/25
Goldman Sachs Keeps Their Hold Rating on Wuxi Biologics (Cayman) (WXIBF)
Jefferies Analyst forecast on HK:2269
Unknown Analyst
Jefferies
Not Ranked
Jefferies
HK$50
Buy
42.94%
Upside
Reiterated
10/08/25
HSBC Analyst forecast on HK:2269
Linda Shu
HSBC
HSBC
HK$37.5→HK$45
Buy
28.64%
Upside
Reiterated
09/26/25
HSBC Sticks to Their Buy Rating for Wuxi Biologics (Cayman) (WXIBF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Wuxi Biologics (Cayman)

3 Months
xxx
Success Rate
6/8 ratings generated profit
75%
Average Return
+16.49%
reiterated a xxx
 rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 75.00% of your transactions generating a profit, with an average return of +16.49% per trade.
1 Year
Yang HuangJ.P. Morgan
Success Rate
4/4 ratings generated profit
100%
Average Return
+53.02%
reiterated a buy rating 8 months ago
Copying Yang Huang's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +53.02% per trade.
2 Years
xxx
Success Rate
4/4 ratings generated profit
100%
Average Return
+56.80%
reiterated a xxx
 rating 8 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +56.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

2269 Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Jan 26
Feb 26
Mar 26
Strong Buy
17
8
4
5
10
Buy
0
0
0
0
0
Hold
5
11
41
52
43
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
19
45
57
53
In the current month, 2269 has received 10 Buy Ratings, 43 Hold Ratings, and 0 Sell Ratings. 2269 average Analyst price target in the past 3 months is 45.14.
Each month's total comprises the sum of three months' worth of ratings.

2269 Financial Forecast

2269 Earnings Forecast

Next quarter’s earnings estimate for 2269 is HK$0.67 with a range of HK$0.67 to HK$0.67. The previous quarter’s EPS was HK$0.70. 2269 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2269 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 2269 is HK$0.67 with a range of HK$0.67 to HK$0.67. The previous quarter’s EPS was HK$0.70. 2269 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 2269 has Performed in-line its overall industry.

2269 Sales Forecast

Next quarter’s sales forecast for 2269 is HK$12.79B with a range of HK$12.79B to HK$12.79B. The previous quarter’s sales results were HK$12.96B. 2269 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2269 has Performed in-line its overall industry.
Next quarter’s sales forecast for 2269 is HK$12.79B with a range of HK$12.79B to HK$12.79B. The previous quarter’s sales results were HK$12.96B. 2269 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 2269 has Performed in-line its overall industry.

2269 Stock Forecast FAQ

What is HK:2269’s average 12-month price target, according to analysts?
Based on analyst ratings, Wuxi Biologics (Cayman) Inc.’s 12-month average price target is 45.14.
    What is HK:2269’s upside potential, based on the analysts’ average price target?
    Wuxi Biologics (Cayman) Inc. has 29.04% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Wuxi Biologics (Cayman) Inc. a Buy, Sell or Hold?
          Wuxi Biologics (Cayman) Inc. has a consensus rating of Strong Buy, which is based on 9 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Wuxi Biologics (Cayman) Inc.’s share price target?
            The average share price target for Wuxi Biologics (Cayman) Inc. is 45.14. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is HK$54.22 ,and the lowest forecast is HK$36.99. The average share price target represents 29.04% Increase from the current price of HK$34.98.
              What do analysts say about Wuxi Biologics (Cayman) Inc.?
              Wuxi Biologics (Cayman) Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
                How can I buy shares of Wuxi Biologics (Cayman) Inc.?
                To buy shares of HK:2269, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.